Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

318 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Proteomic analysis of the cell-surface membrane in chronic lymphocytic leukemia: identification of two novel proteins, BCNP1 and MIG2B.
Boyd RS, Adam PJ, Patel S, Loader JA, Berry J, Redpath NT, Poyser HR, Fletcher GC, Burgess NA, Stamps AC, Hudson L, Smith P, Griffiths M, Willis TG, Karran EL, Oscier DG, Catovsky D, Terrett JA, Dyer MJ. Boyd RS, et al. Among authors: dyer mj. Leukemia. 2003 Aug;17(8):1605-12. doi: 10.1038/sj.leu.2402993. Leukemia. 2003. PMID: 12886250
Inhibition of bortezomib-induced apoptosis by red blood cell uptake.
Wheat LM, Kohlhaas SL, Monbaliu J, De Coster R, Majid A, Walewska RJ, Dyer MJ. Wheat LM, et al. Among authors: dyer mj. Leukemia. 2006 Sep;20(9):1646-9. doi: 10.1038/sj.leu.2404290. Epub 2006 Jun 22. Leukemia. 2006. PMID: 16791268 No abstract available.
A comprehensive genetic and histopathologic analysis identifies two subgroups of B-cell malignancies carrying a t(14;19)(q32;q13) or variant BCL3-translocation.
Martín-Subero JI, Ibbotson R, Klapper W, Michaux L, Callet-Bauchu E, Berger F, Calasanz MJ, De Wolf-Peeters C, Dyer MJ, Felman P, Gardiner A, Gascoyne RD, Gesk S, Harder L, Horsman DE, Kneba M, Küppers R, Majid A, Parry-Jones N, Ritgen M, Salido M, Solé F, Thiel G, Wacker HH, Oscier D, Wlodarska I, Siebert R. Martín-Subero JI, et al. Among authors: dyer mj. Leukemia. 2007 Jul;21(7):1532-44. doi: 10.1038/sj.leu.2404695. Epub 2007 May 10. Leukemia. 2007. PMID: 17495977
Male preponderance in chronic lymphocytic leukemia utilizing IGHV 1-69.
Walewska R, Majid A, Davis Z, Dusanjh P, Kennedy DB, Oscier DG, Dyer MJ. Walewska R, et al. Among authors: dyer mj. Leukemia. 2007 Dec;21(12):2537-8. doi: 10.1038/sj.leu.2404836. Epub 2007 Jun 28. Leukemia. 2007. PMID: 17597803 No abstract available.
TRAIL signals to apoptosis in chronic lymphocytic leukaemia cells primarily through TRAIL-R1 whereas cross-linked agonistic TRAIL-R2 antibodies facilitate signalling via TRAIL-R2.
Natoni A, MacFarlane M, Inoue S, Walewska R, Majid A, Knee D, Stover DR, Dyer MJ, Cohen GM. Natoni A, et al. Among authors: dyer mj. Br J Haematol. 2007 Nov;139(4):568-77. doi: 10.1111/j.1365-2141.2007.06852.x. Epub 2007 Oct 8. Br J Haematol. 2007. PMID: 17922877 Free article.
Mutation status of the residual ATM allele is an important determinant of the cellular response to chemotherapy and survival in patients with chronic lymphocytic leukemia containing an 11q deletion.
Austen B, Skowronska A, Baker C, Powell JE, Gardiner A, Oscier D, Majid A, Dyer M, Siebert R, Taylor AM, Moss PA, Stankovic T. Austen B, et al. J Clin Oncol. 2007 Dec 1;25(34):5448-57. doi: 10.1200/JCO.2007.11.2649. Epub 2007 Oct 29. J Clin Oncol. 2007. PMID: 17968022
318 results